David C Hodgson insider trades
Open-market stock purchases and sales by David C Hodgson, Director at Royalty Pharma plc, from SEC Form 4 filings since Dec 15, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +124%.